TNNT2 and heart failure: In our study, we could find no increased risk of elevated cTnT among patients who received chloroquine phosphate as compared to those who did not, and the slightly elevated NT-proBNP levels indicating possible or probable heart failure (50% in the study group versus 43% in the control group) were not statistically significant.